Cargando…
Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis
BACKGROUND: Immunoglobulin A nephropathy (IgAN) is a progressive inflammatory kidney disease requiring long-term treatment to reduce the risk of progression to kidney failure. Here, we present two systematic literature reviews (SLRs) to identify and summarize literature reporting the humanistic and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471536/ https://www.ncbi.nlm.nih.gov/pubmed/37103750 http://dx.doi.org/10.1007/s41669-023-00415-0 |
_version_ | 1785099870704500736 |
---|---|
author | Jhaveri, Kenar D. Bensink, Mark E. Bunke, Martin Briggs, Jonathon A. Cork, David M. W. Jeyabalan, Anushya |
author_facet | Jhaveri, Kenar D. Bensink, Mark E. Bunke, Martin Briggs, Jonathon A. Cork, David M. W. Jeyabalan, Anushya |
author_sort | Jhaveri, Kenar D. |
collection | PubMed |
description | BACKGROUND: Immunoglobulin A nephropathy (IgAN) is a progressive inflammatory kidney disease requiring long-term treatment to reduce the risk of progression to kidney failure. Here, we present two systematic literature reviews (SLRs) to identify and summarize literature reporting the humanistic and economic burden of IgAN. METHODS: Electronic literature databases (Ovid Embase, PubMed, and Cochrane) were searched for relevant literature on 29 November 2021, supplemented with gray literature searches. Studies reporting any health-related quality of life (HRQoL) or health state utility outcomes in IgAN patients were included in the humanistic impact SLR, and studies reporting the costs and healthcare resource utilization associated with or economic models of IgAN disease management were included in the economic burden SLR. Narrative synthesis was used to discuss the heterogeneous studies included in the SLRs. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines were followed, and all included studies were assessed for risk of bias using the Center for Evidence-Based Management tool for Critical Appraisal of a Survey or the Drummond Checklist. RESULTS: A total of 876 and 1122 references were identified from electronic and gray literature searches for humanistic and economic burden, respectively. Three studies reporting humanistic impact and five studies reporting economic burden met criteria for inclusion in these SLRs. The included humanistic studies reported patient preferences in the USA and China, HRQoL for patients with IgAN in Poland, and impact of exercise on HRQoL for patients with IgAN in China. The five economic studies reported costs of IgAN treatment in Canada, Italy, and China, along with two economic models from Japan. DISCUSSION: Current literature suggests IgAN is associated with substantial humanistic and economic burdens. However, these SLRs demonstrate the paucity of research conducted to specifically describe the humanistic or economic burden of IgAN and highlight the need for further research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-023-00415-0. |
format | Online Article Text |
id | pubmed-10471536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104715362023-09-02 Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis Jhaveri, Kenar D. Bensink, Mark E. Bunke, Martin Briggs, Jonathon A. Cork, David M. W. Jeyabalan, Anushya Pharmacoecon Open Systematic Review BACKGROUND: Immunoglobulin A nephropathy (IgAN) is a progressive inflammatory kidney disease requiring long-term treatment to reduce the risk of progression to kidney failure. Here, we present two systematic literature reviews (SLRs) to identify and summarize literature reporting the humanistic and economic burden of IgAN. METHODS: Electronic literature databases (Ovid Embase, PubMed, and Cochrane) were searched for relevant literature on 29 November 2021, supplemented with gray literature searches. Studies reporting any health-related quality of life (HRQoL) or health state utility outcomes in IgAN patients were included in the humanistic impact SLR, and studies reporting the costs and healthcare resource utilization associated with or economic models of IgAN disease management were included in the economic burden SLR. Narrative synthesis was used to discuss the heterogeneous studies included in the SLRs. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines were followed, and all included studies were assessed for risk of bias using the Center for Evidence-Based Management tool for Critical Appraisal of a Survey or the Drummond Checklist. RESULTS: A total of 876 and 1122 references were identified from electronic and gray literature searches for humanistic and economic burden, respectively. Three studies reporting humanistic impact and five studies reporting economic burden met criteria for inclusion in these SLRs. The included humanistic studies reported patient preferences in the USA and China, HRQoL for patients with IgAN in Poland, and impact of exercise on HRQoL for patients with IgAN in China. The five economic studies reported costs of IgAN treatment in Canada, Italy, and China, along with two economic models from Japan. DISCUSSION: Current literature suggests IgAN is associated with substantial humanistic and economic burdens. However, these SLRs demonstrate the paucity of research conducted to specifically describe the humanistic or economic burden of IgAN and highlight the need for further research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-023-00415-0. Springer International Publishing 2023-04-27 /pmc/articles/PMC10471536/ /pubmed/37103750 http://dx.doi.org/10.1007/s41669-023-00415-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Systematic Review Jhaveri, Kenar D. Bensink, Mark E. Bunke, Martin Briggs, Jonathon A. Cork, David M. W. Jeyabalan, Anushya Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title | Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title_full | Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title_fullStr | Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title_full_unstemmed | Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title_short | Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis |
title_sort | humanistic and economic burden of iga nephropathy: systematic literature reviews and narrative synthesis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471536/ https://www.ncbi.nlm.nih.gov/pubmed/37103750 http://dx.doi.org/10.1007/s41669-023-00415-0 |
work_keys_str_mv | AT jhaverikenard humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis AT bensinkmarke humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis AT bunkemartin humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis AT briggsjonathona humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis AT corkdavidmw humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis AT jeyabalananushya humanisticandeconomicburdenofiganephropathysystematicliteraturereviewsandnarrativesynthesis |